Diamond, Terry, Sambrook, Phil, Williamson, Margaret, Flicker, Leon, Nowson, Caryl, Fiatarone-Singh, Maria, Lord, Sheila, Ferris, Linda, O`Neil, Stephen and MacLennan, Alistair 2001, Guidelines for treatment of osteoporosis in men, Australian family physician, vol. 30, no. 8, pp. 787-791.
(Some files may be inaccessible until you login with your DRO credentials)
BACKGROUND: Osteoporosis is associated with significant morbidity and mortality in men. Published randomised controlled trials assessing the benefits of therapy in men with osteoporosis are limited, but those available need to be used to develop management guidelines.
OBJECTIVE: To present evidence based guidelines for the treatment of osteoporosis in men.
DISCUSSION: It is estimated that 30-60% of men presenting with spinal fractures have another illness contributing to their bone disease. Therefore assessment and treatment of coexisting medical conditions is a vital part of management of osteoporosis. While primary prevention of fractures remains crucial, treatment to ensure further fractures do not occur is equally important. Alendronate is the treatment of choice for men with osteoporosis and fractures, with cyclical etidronate an appropriate alternative and testosterone replacement therapy is indicated in hypogonadal men presenting with osteoporosis.
Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners.
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact email@example.com.